https://news.medxy.ai/ja/remote-cbt-chest-pain/Medxy AIja2026-10-08T09:35:41-07:00救急外来で低リスク胸痛を呈した不安患者への遠隔CBT：PACER無作為化臨床試験からの知見 https://news.medxy.ai/vi/remote-cbt-anxiety/Medxy AIvi2026-10-08T09:35:19-07:00CBT qua y tế từ xa cho lo âu ở bệnh nhân đau ngực nguy cơ thấp tại khoa cấp cứu: Góc nhìn từ thử nghiệm lâm sàng ngẫu nhiên PACER https://news.medxy.ai/telehealth-cognitive-behavioral-therapy-for-anxiety-in-emergency-department-patients-with-low-risk-chest-pain-insights-from-the-pacer-randomized-clinical-trial/Medxy AIen2026-10-08T09:34:57-07:00Telehealth Cognitive Behavioral Therapy for Anxiety in Emergency Department Patients with Low-Risk Chest Pain: Insights from the PACER Randomized Clinical Trial https://news.medxy.ai/zh/education-supervision-recovery/Medxy AIzh2026-10-08T09:34:12-07:00教育加监督运动，助力前交叉韧带重建后年轻成人恢复：一项随机试验 https://news.medxy.ai/ja/acl-reconstruction-outcomes/Medxy AIja2026-10-08T09:33:50-07:00患者教育を併用した監督下運動療法は、ACL再建後の若年成人の転帰を改善する：ランダム化試験 https://news.medxy.ai/vi/supervised-training-outcomes/Medxy AIvi2026-10-08T09:33:26-07:00Tập luyện có giám sát kết hợp giáo dục giúp cải thiện kết cục ở người trẻ sau tái tạo dây chằng chéo trước: một thử nghiệm ngẫu nhiên https://news.medxy.ai/supervised-exercise-therapy-with-education-improves-outcomes-in-young-adults-after-acl-reconstruction-a-randomized-trial/Medxy AIen2026-10-08T09:32:59-07:00Supervised Exercise Therapy with Education Improves Outcomes in Young Adults After ACL Reconstruction: A Randomized Trial https://news.medxy.ai/zh/allogeneic-transplant-outcomes/Medxy AIzh2026-10-08T09:32:17-07:00年轻成人骨髓增生异常综合征异基因造血细胞移植结局：EBMT慢性恶性肿瘤工作组研究启示 https://news.medxy.ai/ja/81730-2/Medxy AIja2026-10-08T09:31:57-07:00若年成人における骨髄異形成症候群への同種造血細胞移植の転帰：EBMT慢性悪性腫瘍ワーキンググループの研究からの示唆 https://news.medxy.ai/vi/hematopoietic-stem-cell-transplant-results/Medxy AIvi2026-10-08T09:31:32-07:00Kết quả ghép tế bào tạo máu dị gen cho hội chứng loạn sản tủy ở người trưởng thành trẻ: Góc nhìn từ Nhóm Công tác Bệnh ác tính mạn tính của EBMT https://news.medxy.ai/outcomes-of-allogeneic-hematopoietic-cell-transplantation-for-myelodysplastic-syndrome-in-young-adults-insights-from-the-ebmt-chronic-malignancies-working-party/Medxy AIen2026-10-08T09:31:11-07:00Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working Party https://news.medxy.ai/zh/81726-2/Medxy AIzh2026-10-08T09:30:31-07:00优化含T细胞造血细胞移植中兔抗胸腺细胞球蛋白（ATG）的暴露水平：基于BMT CTN 1202研究的分析 https://news.medxy.ai/ja/81725-2/Medxy AIja2026-10-08T09:30:09-07:00T細胞除去を行わない造血幹細胞移植におけるウサギATG曝露の最適化：BMT CTN 1202試験の解析 https://news.medxy.ai/vi/optimize-rabbit-atg-exposure/Medxy AIvi2026-10-08T09:29:30-07:00Tối ưu hóa phơi nhiễm rabbit ATG trong ghép tế bào tạo máu còn T đầy đủ: phân tích từ BMT CTN 1202 https://news.medxy.ai/optimizing-rabbit-atg-exposure-in-t-replete-hematopoietic-cell-transplantation-insights-from-bmt-ctn-1202/Medxy AIen2026-10-08T09:29:02-07:00Optimizing Rabbit ATG Exposure in T-Replete Hematopoietic Cell Transplantation: Insights from BMT CTN 1202 https://news.medxy.ai/zh/cd70-acute-leukemia-stem-cells/Medxy AIzh2026-10-08T09:28:17-07:00瞄准不适合强化治疗的急性髓系白血病白血病干细胞：CD70 定向第三药在 ELEVATE 试验中的前景与局限 https://news.medxy.ai/ja/cd70-aml-treatment/Medxy AIja2026-10-08T09:27:54-07:00CD70標的の第三剤で切り込む、治療困難AMLの白血病幹細胞―ELEVATE試験が示す期待と留意点 https://news.medxy.ai/vi/leukemia-stem-cell-targeting/Medxy AIvi2026-10-08T09:27:23-07:00Nhắm đích tế bào gốc bạch cầu trong bệnh bạch cầu tủy cấp không đủ điều kiện điều trị: hy vọng và lưu ý từ thử nghiệm ELEVATE https://news.medxy.ai/targeting-leukemia-stem-cells-in-unfit-acute-myeloid-leukemia-with-a-cd70-directed-third-agent-promise-and-caveats-from-the-elevate-trial/Medxy AIen2026-10-08T09:26:57-07:00Targeting Leukemia Stem Cells in Unfit Acute Myeloid Leukemia with a CD70-Directed Third Agent: Promise and Caveats from the ELEVATE Trial https://news.medxy.ai/zh/cd25-gvhd-prevention/Medxy AIzh2026-10-08T09:25:26-07:00半相合造血干细胞移植后基于CD25的移植物抗宿主病预防：两种预防方案的比较分析 https://news.medxy.ai/ja/cd25-gvhd-prevention-2/Medxy AIja2026-10-08T09:25:06-07:00haplo-HSCT後のCD25ベースGVHD予防：2つの予防レジメンを比較する https://news.medxy.ai/vi/cd25-gvhd-prophylaxis/Medxy AIvi2026-10-08T09:24:42-07:00Dự phòng bệnh ghép chống chủ thể dựa trên CD25 sau ghép tế bào gốc tạo máu đồng loại nửa hòa hợp: phân tích so sánh hai phác đồ dự phòng https://news.medxy.ai/cd25-based-graft-versus-host-disease-prophylaxis-after-haploidentical-hematopoietic-stem-cell-transplantation-comparative-analysis-of-two-prophylactic-regimens/Medxy AIen2026-10-08T09:24:16-07:00CD25-based Graft-versus-Host Disease Prophylaxis after Haploidentical Hematopoietic Stem Cell Transplantation: Comparative Analysis of Two Prophylactic Regimens https://news.medxy.ai/influence-of-clonal-hematopoiesis-and-neutropenia-on-car-t-therapy-outcomes-in-hematologic-malignancies/Medxy AIen2026-10-08T09:23:22-07:00Influence of Clonal Hematopoiesis and Neutropenia on CAR-T Therapy Outcomes in Hematologic Malignancies https://news.medxy.ai/zh/target-aml-stemcells/Medxy AIzh2026-10-08T09:22:38-07:00靶向急性髓系白血病白血病干细胞：通过表观遗传调控克服 PI3K 抑制剂耐药 https://news.medxy.ai/ja/aml-leukemia-targeting/Medxy AIja2026-10-08T09:22:19-07:00AMLの白血病幹細胞を狙い撃ち：エピジェネティック制御でPI3K阻害抵抗性を打破する https://news.medxy.ai/vi/aml-leukemia-treatment/Medxy AIvi2026-10-08T09:21:54-07:00Nhắm vào tế bào gốc bạch cầu trong AML: Vượt qua kháng thuốc với chất ức chế PI3K bằng điều hòa biểu sinh https://news.medxy.ai/targeting-leukemic-stem-cells-in-aml-overcoming-pi3k-inhibitor-resistance-through-epigenetic-modulation/Medxy AIen2026-10-08T09:21:30-07:00Targeting Leukemic Stem Cells in AML: Overcoming PI3K Inhibitor Resistance through Epigenetic Modulation https://news.medxy.ai/zh/ror1-chronic-lymphocytic-leukemia/Medxy AIzh2026-10-08T09:20:49-07:00靶向慢性淋巴细胞白血病中的 ROR1：Zilovertamab 联合 Ibrutinib 在高风险 del(17p) 疾病中的研究启示 https://news.medxy.ai/ja/81703-2/Medxy AIja2026-10-08T09:20:29-07:00慢性リンパ球性白血病におけるROR1を標的とした治療：高リスクdel(17p)症例に対するZilovertamabとイブルチニブの併用療法に関する研究の示唆 https://news.medxy.ai/vi/81702-2/Medxy AIvi2026-10-08T09:20:05-07:00Nhắm đích ROR1 trong bệnh bạch cầu lympho mạn tính: Những hiểu biết từ các nghiên cứu về Zilovertamab kết hợp với Ibrutinib ở bệnh nhân có nguy cơ cao mang đột biến del(17p) https://news.medxy.ai/targeting-ror1-in-chronic-lymphocytic-leukemia-insights-from-the-zilovertamab-and-ibrutinib-combination-in-high-risk-del17p-disease/Medxy AIen2026-10-08T09:19:42-07:00Targeting ROR1 in Chronic Lymphocytic Leukemia: Insights from the Zilovertamab and Ibrutinib Combination in High-Risk del(17p) Disease https://news.medxy.ai/zh/ibrutinib-venetoclax-longterm-results/Medxy AIzh2026-10-08T09:18:46-07:00老年慢性淋巴细胞白血病一线 ibrutinib-venetoclax 的长期疗效与安全性：GLOW 研究 67 个月结果解读 https://news.medxy.ai/ja/ibrutinib-venetoclax-long-term/Medxy AIja2026-10-08T09:18:21-07:00高齢の慢性リンパ性白血病患者における一次治療ibrutinib-venetoclaxの長期有効性と安全性：GLOW試験67か月成績からの示唆 https://news.medxy.ai/vi/ibrutinib-venetoclax-results/Medxy AIvi2026-10-08T09:17:53-07:00Ibrutinib-venetoclax bước một: Hiệu quả và độ an toàn dài hạn ở bệnh bạch cầu lympho mạn tính giai đoạn muộn từ nghiên cứu GLOW 67 tháng https://news.medxy.ai/zh/ctcl-cancer-pathways/Medxy AIzh2026-10-08T09:16:43-07:00解码CTCL：单细胞图谱揭示致癌通路与免疫耐受机制 https://news.medxy.ai/ja/81693-2/Medxy AIja2026-10-08T09:16:25-07:00CTCLの解明：シングルセル・アトラスが明らかにする発がん経路と免疫寛容メカニズム https://news.medxy.ai/vi/ctcl-single-cell-map/Medxy AIvi2026-10-08T09:15:58-07:00Giải mã CTCL: Bản đồ đơn bào hé lộ các con đường sinh ung và cơ chế kháng miễn dịch https://news.medxy.ai/zh/lisocabtagene-followup/Medxy AIzh2026-10-08T09:14:49-07:00lisocabtagene maraleucel 三年随访：复发/难治性滤泡性淋巴瘤中缓解持久且安全性可控 https://news.medxy.ai/ja/relapsed-follicular-lymphoma/Medxy AIja2026-10-08T09:14:27-07:00再発・難治性濾胞性リンパ腫におけるリソカブタゲン マラルユーセル：3年追跡で示された持続的寛解と良好な安全性 https://news.medxy.ai/vi/lisocabtagene-maraleucel-followup/Medxy AIvi2026-10-08T09:14:02-07:00Theo dõi 3 năm lisocabtagene maraleucel: lui bệnh bền vững và an toàn có thể kiểm soát ở u lympho nang tái phát/kháng trị https://news.medxy.ai/zh/tisa-818-ards-study/Medxy AIzh2026-10-08T08:52:32-07:00肺部感染相关ARDS中TISA-818的Ⅱ期研究：基于2023年全球定义的安全性良好与早期疗效信号 https://news.medxy.ai/ja/81683-2/Medxy AIja2026-10-08T08:52:10-07:00肺炎関連ARDSにおけるTISA-818の第II相試験：2023年の世界的な定義に基づく良好な安全性および早期の有効性シグナル https://news.medxy.ai/vi/tisa-ards-safety/Medxy AIvi2026-10-08T08:51:46-07:00TISA-818 trong ARDS do nhiễm trùng phổi: tín hiệu an toàn khả quan và hiệu quả sớm đầy hứa hẹn theo định nghĩa toàn cầu năm 2023 https://news.medxy.ai/tisa-818-in-ards-due-to-pulmonary-infection-promising-safety-and-early-efficacy-signals-with-the-2023-global-definition/Medxy AIen2026-10-08T08:51:23-07:00TISA-818 in ARDS Due to Pulmonary Infection: Promising Safety and Early Efficacy Signals with the 2023 Global Definition https://news.medxy.ai/zh/ceus-biopsy-accuracy/Medxy AIzh2026-10-08T08:50:44-07:00CEUS引导活检显著提升下胸膜肺病变诊断准确性与安全性：大型多中心RCT的启示 https://news.medxy.ai/ja/81678-2/Medxy AIja2026-10-08T08:50:24-07:00CEUSガイド下生検は下胸膜肺病変の診断精度と安全性を著しく向上させる：大規模多施設共同RCTからの示唆 https://news.medxy.ai/vi/81677-2/Medxy AIvi2026-10-08T08:49:58-07:00Sinh thiết dưới hướng dẫn của CEUS giúp cải thiện đáng kể độ chính xác trong chẩn đoán và độ an toàn đối với các tổn thương phổi nằm dưới màng phổi https://news.medxy.ai/enhanced-diagnostic-accuracy-and-safety-of-ceus-guided-biopsy-for-subpleural-lung-lesions-insights-from-a-large-multicenter-rct/Medxy AIen2026-10-08T08:49:31-07:00Enhanced Diagnostic Accuracy and Safety of CEUS-Guided Biopsy for Subpleural Lung Lesions: Insights from a Large Multicenter RCT https://news.medxy.ai/zh/sputum-cell-composition/Medxy AIzh2026-10-08T08:48:51-07:00痰液细胞组成与哮喘、COPD 的医疗服务利用：炎症表型与临床结局的启示 https://news.medxy.ai/ja/81673-2/Medxy AIja2026-10-08T08:48:24-07:00喀痰細胞組成と喘息・COPDにおける医療サービス利用：炎症表現型と臨床転帰からの示唆 https://news.medxy.ai/vi/sputum-leukocytes-copd-asthma/Medxy AIvi2026-10-08T08:47:55-07:00Bạch cầu trong đờm và mức sử dụng dịch vụ y tế ở hen và COPD: gợi ý về kiểu hình viêm và kết cục lâm sàng https://news.medxy.ai/sputum-cellularity-and-health-services-utilization-in-asthma-and-copd-insights-into-inflammatory-phenotypes-and-clinical-outcomes/Medxy AIen2026-10-08T08:47:27-07:00Sputum Cellularity and Health Services Utilization in Asthma and COPD: Insights into Inflammatory Phenotypes and Clinical Outcomes https://news.medxy.ai/zh/polygenic-risk-score/Medxy AIzh2026-10-08T08:29:52-07:00多基因风险评分有助于提升特发性肺纤维化的诊断与预后分层 https://news.medxy.ai/ja/idiopathic-pulmonary-fibrosis-risk/Medxy AIja2026-10-08T08:29:37-07:00特発性肺線維症の診断と予後層別化を高める多遺伝子リスクスコア https://news.medxy.ai/vi/polygenic-risk-ipf/Medxy AIvi2026-10-08T08:29:18-07:00Điểm nguy cơ đa gen hỗ trợ chẩn đoán và phân tầng tiên lượng ở xơ phổi vô căn https://news.medxy.ai/polygenic-risk-score-enhances-diagnosis-and-prognostic-stratification-in-idiopathic-pulmonary-fibrosis/Medxy AIen2026-10-08T08:28:58-07:00Polygenic Risk Score Enhances Diagnosis and Prognostic Stratification in Idiopathic Pulmonary Fibrosis https://news.medxy.ai/zh/immune-pneumonitis-duration/Medxy AIzh2026-10-08T08:28:07-07:00轻度免疫相关肺炎：糖皮质激素疗程应选3周还是6周？随机试验给出答案 https://news.medxy.ai/ja/steroid-treatment-duration/Medxy AIja2026-10-08T08:27:49-07:00軽症の免疫関連肺臓炎に対する最適な副腎皮質ステロイド投与期間を検証する：ランダム化試験からの知見 https://news.medxy.ai/vi/optimal-corticosteroid-duration/Medxy AIvi2026-10-08T08:27:32-07:00Xác định thời gian dùng corticosteroid tối ưu cho viêm phổi liên quan đến miễn dịch mức độ nhẹ: góc nhìn từ một thử nghiệm ngẫu nhiên https://news.medxy.ai/evaluating-optimal-corticosteroid-duration-for-mild-immune-related-pneumonitis-insights-from-a-randomized-trial/Medxy AIen2026-10-08T08:27:14-07:00Evaluating Optimal Corticosteroid Duration for Mild Immune-Related Pneumonitis: Insights from a Randomized Trial https://news.medxy.ai/zh/mycophenolate-vs-azathioprine/Medxy AIzh2026-10-08T08:26:34-07:00纤维化性间质性肺疾病中吗替麦考酚酯与硫唑嘌呤的疗效评估：多中心回顾性研究带来的启示 https://news.medxy.ai/ja/mycophenolate-azathioprine-study/Medxy AIja2026-10-08T08:26:15-07:00線維性間質性肺疾患におけるミコフェノール酸モフェチルとアザチオプリン：多施設後ろ向き研究から見えたもの https://news.medxy.ai/vi/mycophenolate-azathioprine-pulmonary-fibrosis/Medxy AIvi2026-10-08T08:25:55-07:00Mycophenolate và azathioprine trong bệnh phổi kẽ xơ hóa: Những phát hiện từ một nghiên cứu hồi cứu đa trung tâm https://news.medxy.ai/evaluating-mycophenolate-and-azathioprine-in-fibrotic-interstitial-lung-disease-insights-from-a-multicenter-retrospective-study/Medxy AIen2026-10-08T08:25:37-07:00Evaluating Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease: Insights from a Multicenter Retrospective Study https://news.medxy.ai/zh/menopause-strabismus/Medxy AIzh2026-10-08T08:24:53-07:00更年期激素治疗与绝经后女性斜视发生及手术结局：有何关联？ https://news.medxy.ai/ja/postmenopausal-hormone-therapy-2/Medxy AIja2026-10-08T08:24:36-07:00閉経後ホルモン療法は斜視発症と手術転帰にどう影響するのか：閉経後女性を対象とした検討 https://news.medxy.ai/vi/menopause-hormone-therapy-impact/Medxy AIvi2026-10-08T08:24:14-07:00Liệu pháp hormone mãn kinh có thể ảnh hưởng thế nào đến lác và kết quả phẫu thuật ở phụ nữ sau mãn kinh https://news.medxy.ai/implications-of-menopausal-hormone-therapy-on-strabismus-incidence-and-surgical-outcomes-in-postmenopausal-women/Medxy AIen2026-10-08T08:23:52-07:00Implications of Menopausal Hormone Therapy on Strabismus Incidence and Surgical Outcomes in Postmenopausal Women https://news.medxy.ai/zh/central-serous-retinopathy/Medxy AIzh2026-10-08T08:23:06-07:00中央浆液性脉络膜视网膜病变中期高荧光斑块：多模态影像揭示其动态演变 https://news.medxy.ai/zh/proton-therapy-uveal-melanoma/Medxy AIzh2026-10-08T08:22:56-07:00眼部质子治疗对葡萄膜黑色素瘤患者角膜基底下神经丛的影响：纵向共聚焦显微镜研究结果 https://news.medxy.ai/ja/central-serous-retinopathy-3/Medxy AIja2026-10-08T08:22:46-07:00中心性漿液性脈絡網膜症における中期高蛍光プラークの解明：マルチモーダル画像から見えた新知見 https://news.medxy.ai/ja/uveal-melanoma-proton-therapy/Medxy AIja2026-10-08T08:22:37-07:00ぶどう膜悪性黒色腫における眼球プロトン療法が角膜上皮下神経叢に及ぼす影響：角膜共焦点顕微鏡による縦断的所見 https://news.medxy.ai/vi/central-serous-retinopathy-2/Medxy AIvi2026-10-08T08:22:26-07:00Giải mã các mảng tăng huỳnh quang ở pha giữa trong bệnh lý hắc võng mạc thanh dịch trung tâm: Góc nhìn từ chẩn đoán hình ảnh đa mô thức https://news.medxy.ai/vi/proton-therapy-effects/Medxy AIvi2026-10-08T08:22:15-07:00Ảnh hưởng của liệu pháp proton nhãn cầu lên đám rối thần kinh dưới nền giác mạc ở uveal melanoma: Phát hiện theo dõi bằng kính hiển vi đồng tiêu https://news.medxy.ai/unraveling-mid-phase-hyperfluorescent-plaques-in-central-serous-chorioretinopathy-insights-from-multimodal-imaging/Medxy AIen2026-10-08T08:22:04-07:00Unraveling Mid-phase Hyperfluorescent Plaques in Central Serous Chorioretinopathy: Insights from Multimodal Imaging https://news.medxy.ai/impact-of-ocular-proton-therapy-on-corneal-subbasal-nerve-plexus-in-uveal-melanoma-longitudinal-confocal-microscopy-findings/Medxy AIen2026-10-08T08:21:54-07:00Impact of Ocular Proton Therapy on Corneal Subbasal Nerve Plexus in Uveal Melanoma: Longitudinal Confocal Microscopy Findings https://news.medxy.ai/zh/temporal-meningioma-prediction/Medxy AIzh2026-10-08T08:21:09-07:00岩斜区与颞骨脑膜瘤手术结局预测：一种新型描述性分层框架的价值 https://news.medxy.ai/ja/petroclival-meningioma-prediction/Medxy AIja2026-10-08T08:20:53-07:00Petroclival・Temporal Bone Meningiomaの手術転帰予測精度を高める新規記述的フレームワーク https://news.medxy.ai/vi/improved-meningioma-surgery-prediction/Medxy AIvi2026-10-08T08:20:34-07:00Khung mô tả mới giúp tăng độ chính xác dự đoán kết cục phẫu thuật u màng não vùng xương đá–dốc nền và xương thái dương https://news.medxy.ai/a-novel-descriptive-framework-enhances-predictive-accuracy-for-surgical-outcomes-in-petroclival-and-temporal-bone-meningiomas/Medxy AIen2026-10-08T08:20:16-07:00A Novel Descriptive Framework Enhances Predictive Accuracy for Surgical Outcomes in Petroclival and Temporal Bone Meningiomas https://news.medxy.ai/zh/bmi-effects-airway-reconstruction/Medxy AIzh2026-10-08T08:19:31-07:00BMI升高会影响开放性气道重建吗？术后结局解析 https://news.medxy.ai/ja/bmi-airway-reconstruction/Medxy AIja2026-10-08T08:19:14-07:00BMI高値でも開放的気道再建の予後は悪化しない：術後転帰への影響を検証 https://news.medxy.ai/vi/high-bmi-airway-reconstruction/Medxy AIvi2026-10-08T08:18:54-07:00BMI cao và tái tạo đường thở mở: Tách bạch tác động lên kết cục sau mổ https://news.medxy.ai/elevated-bmi-and-open-airway-reconstruction-disentangling-the-impact-on-postoperative-outcomes/Medxy AIen2026-10-08T08:18:32-07:00Elevated BMI and Open Airway Reconstruction: Disentangling the Impact on Postoperative Outcomes https://news.medxy.ai/zh/tranexamic-acid-safety/Medxy AIzh2026-10-08T08:17:53-07:00头颈部游离皮瓣重建中氨甲环酸的安全性与疗效：一项回顾性队列研究 https://news.medxy.ai/ja/81628-2/Medxy AIja2026-10-08T08:17:37-07:00頭頸部における遊離皮弁再建術でのトラネキサム酸の安全性と有効性の評価：後方視的コホート研究からの検討 https://news.medxy.ai/long-term-efficacy-and-safety-of-first-line-ibrutinib-venetoclax-in-older-patients-with-chronic-lymphocytic-leukemia-insights-from-the-67-month-glow-study/Medxy AIen2026-10-08T08:17:31-07:00Long-Term Efficacy and Safety of First-Line Ibrutinib-Venetoclax in Older Patients with Chronic Lymphocytic Leukemia: Insights from the 67-Month GLOW Study https://news.medxy.ai/vi/tranexamic-acid-safety-3/Medxy AIvi2026-10-08T08:17:17-07:00Đánh giá độ an toàn và hiệu quả của acid tranexamic trong tái tạo vạt tự do vùng đầu và cổ: Góc nhìn từ một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/tranexamic-acid-safety-2/Medxy AIen2026-10-08T08:16:56-07:00Evaluating Tranexamic Acid’s Safety and Efficacy in Head and Neck Free Flap Reconstruction: Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/bedside-stomach-ultrasound/Medxy AIzh2026-10-08T08:16:16-07:00护士实施胃部床旁超声用于术后胃内容物评估：可行性与临床应用价值 https://news.medxy.ai/ja/g-pocus-stomach-evaluation/Medxy AIja2026-10-08T08:15:58-07:00術後胃内容評価における胃POCUS（G-POCUS）の実施可能性と臨床的有用性 https://news.medxy.ai/vi/bedside-stomach-ultrasound-2/Medxy AIvi2026-10-08T08:15:38-07:00Siêu âm tại giường dạ dày (G-POCUS) trong đánh giá hậu phẫu: tính khả thi và giá trị lâm sàng https://news.medxy.ai/decoding-ctcl-a-single-cell-atlas-reveals-oncogenic-pathways-and-immune-resistance-mechanisms/Medxy AIen2026-10-08T08:15:35-07:00Decoding CTCL: A Single-Cell Atlas Reveals Oncogenic Pathways and Immune Resistance Mechanisms https://news.medxy.ai/feasibility-and-clinical-utility-of-gastric-point-of-care-ultrasound-g-pocus-for-postoperative-gastric-content-assessment/Medxy AIen2026-10-08T08:15:14-07:00Feasibility and Clinical Utility of Gastric Point-of-Care Ultrasound (G-POCUS) for Postoperative Gastric Content Assessment https://news.medxy.ai/zh/breast-cancer-treatment/Medxy AIzh2026-10-08T08:14:35-07:00乳腺癌年轻女性的外科治疗模式与结局如何演变：基于十年国家数据库的洞见 https://news.medxy.ai/ja/young-female-breast-cancer-surgery/Medxy AIja2026-10-08T08:14:17-07:00若年乳癌女性における外科治療の変化と転帰：全国データ10年分から見えたこと https://news.medxy.ai/vi/breast-cancer-trends-2/Medxy AIvi2026-10-08T08:13:58-07:00Xu hướng phẫu thuật và kết cục ở phụ nữ trẻ mắc ung thư vú: Góc nhìn từ dữ liệu quốc gia trong 10 năm https://news.medxy.ai/evolving-surgical-patterns-and-outcomes-in-young-women-with-breast-cancer-insights-from-a-decade-of-national-data/Medxy AIen2026-10-08T08:13:38-07:00Evolving Surgical Patterns and Outcomes in Young Women with Breast Cancer: Insights from a Decade of National Data https://news.medxy.ai/zh/peripheral-venous-nutrition/Medxy AIzh2026-10-07T07:12:57-07:00外周静脉营养可减轻结直肠手术后炎症并促进营养恢复：一项随机试验的启示 https://news.medxy.ai/ja/post-colorectal-surgery-nutrition/Medxy AIja2026-10-07T07:12:39-07:00結腸直腸手術後の炎症を抑え、栄養回復を高める末梢静脈栄養：ランダム化試験からの知見 https://news.medxy.ai/vi/peripheral-vein-nutrition/Medxy AIvi2026-10-07T07:12:21-07:00Dinh dưỡng tĩnh mạch ngoại vi giúp giảm viêm và cải thiện hồi phục dinh dưỡng sau phẫu thuật đại trực tràng: Góc nhìn từ một thử nghiệm ngẫu nhiên https://news.medxy.ai/peripheral-parenteral-nutrition-reduces-inflammation-and-enhances-nutritional-recovery-after-colorectal-surgery-insights-from-a-randomized-trial/Medxy AIen2026-10-07T07:12:03-07:00Peripheral Parenteral Nutrition Reduces Inflammation and Enhances Nutritional Recovery After Colorectal Surgery: Insights from a Randomized Trial https://news.medxy.ai/zh/ai-driven-3d-liver-modeling/Medxy AIzh2026-10-07T07:11:27-07:00AI驱动的三维肝脏建模：提升术前CT预测肝切除复杂度的能力 https://news.medxy.ai/ja/ai-3d-liver-modeling/Medxy AIja2026-10-07T07:11:12-07:00AIが切り拓く3D肝モデリング：術前CTから肝切除難度を高精度予測 https://news.medxy.ai/vi/3d-liver-ai-model/Medxy AIvi2026-10-07T07:10:49-07:00AI tạo mô hình gan 3D: Dự đoán chính xác độ phức tạp cắt gan từ CT trước mổ https://news.medxy.ai/ai-driven-3d-liver-modeling-enhances-prediction-of-liver-resection-complexity-from-preoperative-ct-scans/Medxy AIen2026-10-07T07:10:31-07:00AI-Driven 3D Liver Modeling Enhances Prediction of Liver Resection Complexity from Preoperative CT Scans https://news.medxy.ai/zh/preoperative-education-opioids/Medxy AIzh2026-10-07T07:09:51-07:00术前患者教育对阿片类药物使用与术后疼痛管理的效果评估：随机试验带来的启示 https://news.medxy.ai/ja/preoperative-education-opioids-2/Medxy AIja2026-10-07T07:09:33-07:00術前患者教育はオピオイド使用と術後疼痛管理に有効か：ランダム化試験から見えた実態 https://news.medxy.ai/vi/preoperative-education-opioid-pain/Medxy AIvi2026-10-07T07:09:13-07:00Giáo dục trước phẫu thuật có thực sự giúp giảm dùng opioid và kiểm soát đau sau mổ? Kết quả từ một thử nghiệm ngẫu nhiên https://news.medxy.ai/evaluating-the-effectiveness-of-preoperative-patient-education-on-opioid-use-and-postoperative-pain-management-insights-from-a-randomized-trial/Medxy AIen2026-10-07T07:08:49-07:00Evaluating the Effectiveness of Preoperative Patient Education on Opioid Use and Postoperative Pain Management: Insights from a Randomized Trial https://news.medxy.ai/zh/hospital-recovery-success/Medxy AIzh2026-10-07T07:08:06-07:00破解实施成功密码：医院情境如何塑造加速康复项目的落地 https://news.medxy.ai/ja/hospital-recovery-success-2/Medxy AIja2026-10-07T07:07:51-07:00病院の文脈が成否を分ける：Enhanced Recovery Programs導入を成功に導く要因とは https://news.medxy.ai/vi/hospital-rehabilitation-success/Medxy AIvi2026-10-07T07:07:32-07:00Giải mã thành công: Bối cảnh bệnh viện định hình triển khai Chương trình Phục hồi tăng cường như thế nào https://news.medxy.ai/decoding-success-how-hospital-contexts-shape-enhanced-recovery-program-implementation/Medxy AIen2026-10-07T07:07:13-07:00Decoding Success: How Hospital Contexts Shape Enhanced Recovery Program Implementation https://news.medxy.ai/zh/glp-1-pregnancy/Medxy AIzh2026-10-07T07:06:38-07:00妊娠期GLP-1受体激动剂：围受孕期暴露与围产结局的评估 https://news.medxy.ai/ja/glp-1-pregnancy-2/Medxy AIja2026-10-07T07:06:17-07:00妊娠中のGLP-1受容体作動薬：受胎前後の曝露と周産期転帰をどう評価するか https://news.medxy.ai/vi/glp-1-receptor-agonists-pregnancy/Medxy AIvi2026-10-07T07:05:54-07:00Chất chủ vận thụ thể GLP-1 trong thai kỳ: Đánh giá phơi nhiễm quanh thụ thai và kết cục chu sinh https://news.medxy.ai/glucagon-like-peptide-1-receptor-agonists-in-pregnancy-evaluating-periconception-exposure-and-perinatal-outcomes/Medxy AIen2026-10-07T07:05:33-07:00Glucagon-Like Peptide-1 Receptor Agonists in Pregnancy: Evaluating Periconception Exposure and Perinatal Outcomes https://news.medxy.ai/zh/preeclampsia-bp-monitoring/Medxy AIzh2026-10-07T07:04:49-07:00先兆子痫高风险孕妇远程血压监测优于门诊随访：一项多中心随机对照试验 https://news.medxy.ai/ja/81588-2/Medxy AIja2026-10-07T07:04:31-07:00子癇前症ハイリスク妊婦における遠隔血圧モニタリングは外来での経過観察より優れている：多施設共同無作為化比較試験 https://news.medxy.ai/vi/remote-bp-monitoring/Medxy AIvi2026-10-07T07:04:12-07:00Theo dõi huyết áp từ xa hay khám tại phòng khám: thử nghiệm ngẫu nhiên đa trung tâm ở thai phụ nguy cơ cao tiền sản giật https://news.medxy.ai/remote-blood-pressure-monitoring-versus-office-visits-in-high-risk-preeclampsia-a-multicenter-rct/Medxy AIen2026-10-07T07:03:51-07:00Remote Blood Pressure Monitoring Versus Office Visits in High-Risk Preeclampsia: A Multicenter RCT https://news.medxy.ai/uterus-preserving-focal-excision-in-placenta-percreta-navigating-neovascularization-challenges-based-on-pathoanatomy/Medxy AIen2026-10-07T07:02:07-07:00Uterus-Preserving Focal Excision in Placenta Percreta: Navigating Neovascularization Challenges Based on Pathoanatomy https://news.medxy.ai/exploring-ultrasound-guided-high-intensity-focused-ultrasound-for-safe-placental-vessel-occlusion-in-early-onset-twin-twin-transfusion-syndrome/Medxy AIen2026-10-07T07:00:29-07:00Exploring Ultrasound-Guided High-Intensity Focused Ultrasound for Safe Placental Vessel Occlusion in Early-Onset Twin-Twin Transfusion Syndrome https://news.medxy.ai/zh/catheter-ablation-value/Medxy AIzh2026-10-07T06:59:39-07:00既往卒中房颤患者早期导管消融的价值：基于目标试验模拟的研究启示 https://news.medxy.ai/ja/early-ablation-afib-stroke/Medxy AIja2026-10-07T06:59:21-07:00脳卒中既往を有する心房細動患者に対する早期カテーテルアブレーションの評価：ターゲット試験エミュレーションからの知見 https://news.medxy.ai/vi/early-catheter-ablation/Medxy AIvi2026-10-07T06:58:58-07:00Đánh giá triệt đốt catheter sớm ở bệnh nhân rung nhĩ có tiền sử đột quỵ: phát hiện từ mô phỏng thử nghiệm mục tiêu https://news.medxy.ai/assessing-early-catheter-ablation-in-atrial-fibrillation-patients-with-prior-stroke-insights-from-a-target-trial-emulation/Medxy AIen2026-10-07T06:58:36-07:00Assessing Early Catheter Ablation in Atrial Fibrillation Patients With Prior Stroke: Insights From a Target Trial Emulation https://news.medxy.ai/zh/81569-2/Medxy AIzh2026-10-07T06:57:49-07:00与血浆p-tau217与阿尔茨海默病生物标志物不一致相关的临床因素 https://news.medxy.ai/ja/ptau217-alzheimers-mismatch/Medxy AIja2026-10-07T06:57:27-07:00血漿p-tau217とアルツハイマー病バイオマーカーの不一致に関わる臨床因子：診断と管理への示唆 https://news.medxy.ai/vi/ptau217-alzheimers-diagnosis/Medxy AIvi2026-10-07T06:57:02-07:00Các yếu tố lâm sàng liên quan đến sự không đồng nhất giữa p-tau217 huyết tương và các dấu ấn sinh học bệnh Alzheimer đã thiết lập: Hàm ý cho chẩn đoán và quản lý https://news.medxy.ai/clinical-factors-associated-with-discordant-plasma-p-tau217-and-established-alzheimer-disease-biomarkers-implications-for-diagnosis-and-management/Medxy AIen2026-10-07T06:56:40-07:00Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers: Implications for Diagnosis and Management https://news.medxy.ai/zh/us-spinal-injury-trends/Medxy AIzh2026-10-07T06:55:35-07:00美国创伤性脊髓损伤死亡趋势（1999—2024）：人口学差异与大流行影响的启示 https://news.medxy.ai/ja/81563-2/Medxy AIja2026-10-07T06:55:17-07:00米国における脊髄損傷による死亡（1999～2024年）：傾向、人口統計学的格差、およびパンデミックの影響 https://news.medxy.ai/vi/spinal-cord-injury-deaths/Medxy AIvi2026-10-07T06:54:56-07:00Tử vong do chấn thương tủy sống tại Hoa Kỳ (1999–2024): Xu hướng, chênh lệch nhân khẩu học và tác động của đại dịch https://news.medxy.ai/traumatic-spinal-cord-injury-mortality-trends-in-the-u-s-1999-2024-insights-into-demographic-disparities-and-pandemic-impact/Medxy AIen2026-10-07T06:54:39-07:00Traumatic Spinal Cord Injury Mortality Trends in the U.S. (1999-2024): Insights into Demographic Disparities and Pandemic Impact https://news.medxy.ai/zh/type-2-diabetes-body-change/Medxy AIzh2026-10-07T06:53:53-07:002型糖尿病诊断前后体成分如何变化？来自欧洲与美国三大队列的纵向证据 https://news.medxy.ai/ja/type-2-diabetes-bodycomposition/Medxy AIja2026-10-07T06:53:37-07:002型糖尿病診断前後の体組成はどう変化するのか：欧州・米国3コホートから見えた動態 https://news.medxy.ai/vi/body-composition-changes/Medxy AIvi2026-10-07T06:53:18-07:00Diễn biến động của thành phần cơ thể quanh thời điểm chẩn đoán đái tháo đường típ 2: Bằng chứng từ ba đoàn hệ châu Âu và Hoa Kỳ https://news.medxy.ai/dynamic-patterns-of-body-composition-remodeling-around-type-2-diabetes-diagnosis-insights-from-three-european-and-us-cohorts/Medxy AIen2026-10-07T06:53:01-07:00Dynamic Patterns of Body Composition Remodeling Around Type 2 Diabetes Diagnosis: Insights from Three European and US Cohorts https://news.medxy.ai/ja/diabetic-foot-ulcer-treatment/Medxy AIja2026-10-07T06:52:15-07:00糖尿病関連足潰瘍のオフローディング治療はどれが環境にやさしいか：ライフサイクルアセスメント https://news.medxy.ai/vi/environmental-sustainability-diabetic-foot/Medxy AIvi2026-10-07T06:51:52-07:00Tính bền vững môi trường của các lộ trình giảm tải trong chăm sóc loét bàn chân do đái tháo đường: Phân tích vòng đời https://news.medxy.ai/environmental-sustainability-of-offloading-care-pathways-for-people-with-diabetes-related-foot-ulcers-a-life-cycle-assessment/Medxy AIen2026-10-07T06:51:32-07:00Environmental Sustainability of Offloading Care Pathways for People with Diabetes-Related Foot Ulcers: A Life-Cycle Assessment https://news.medxy.ai/zh/prolactinoma-management/Medxy AIzh2026-10-07T06:50:51-07:00妊娠期泌乳素瘤管理：以证据为基础，兼顾母胎最佳结局 https://news.medxy.ai/ja/prolactinoma-pregnancy-management/Medxy AIja2026-10-07T06:50:32-07:00妊娠中のプロラクチノーマをどう管理するか：母児の良好な転帰を目指すエビデンスに基づく実践 https://news.medxy.ai/vi/prolactinoma-pregnancy-management-2/Medxy AIvi2026-10-07T06:49:47-07:00Quản lý prolactinoma trong thai kỳ: Tiếp cận dựa trên bằng chứng để tối ưu kết cục cho mẹ và thai nhi https://news.medxy.ai/navigating-prolactinomas-in-pregnancy-an-evidence-based-approach-for-optimal-maternal-and-fetal-outcomes/Medxy AIen2026-10-07T06:49:26-07:00Navigating Prolactinomas in Pregnancy: An Evidence-Based Approach for Optimal Maternal and Fetal Outcomes https://news.medxy.ai/ja/hypothalamic-amenorrhea-risk/Medxy AIja2026-10-07T06:48:35-07:00機能性視床下部性無月経の表現型と心血管疾患リスク https://news.medxy.ai/vi/hypogonadism-cvd-risk/Medxy AIvi2026-10-07T06:48:16-07:00Vô kinh vùng dưới đồi chức năng và nguy cơ bệnh tim mạch: Kiểu hình cần được nhận diện sớm https://news.medxy.ai/functional-hypothalamic-amenorrhea-phenotype-and-cardiovascular-disease-risk/Medxy AIen2026-10-07T06:47:59-07:00Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk https://news.medxy.ai/zh/maternal-protection-type-1-diabetes/Medxy AIzh2026-10-07T06:47:23-07:00揭示母体对1型糖尿病的保护作用：遗传风险与宫内影响 https://news.medxy.ai/ja/81540-2/Medxy AIja2026-10-07T06:47:07-07:001型糖尿病に対する母体由来の保護作用の解明：遺伝的リスクと子宮内環境の影響 https://news.medxy.ai/vi/type-1-diabetes-risk-2/Medxy AIvi2026-10-07T06:46:48-07:00Vì sao con của mẹ mắc đái tháo đường týp 1 có nguy cơ thấp hơn? Vai trò của di truyền và môi trường trong tử cung https://news.medxy.ai/unraveling-maternal-protection-against-type-1-diabetes-genetic-risk-and-intrauterine-influences/Medxy AIen2026-10-07T06:46:31-07:00Unraveling Maternal Protection Against Type 1 Diabetes: Genetic Risk and Intrauterine Influences https://news.medxy.ai/zh/syndecan4-piezo1-thrombosis/Medxy AIzh2026-10-07T06:45:45-07:00揭示 Syndecan-4 与 Piezo1 在深静脉血栓形成中的机制作用：槲皮素带来的治疗启示 https://news.medxy.ai/ja/81535-2/Medxy AIja2026-10-07T06:45:23-07:00深部静脈血栓症におけるSyndecan-4およびPiezo1の役割とメカニズムの解明：ケルセチンによる治療への示唆 https://news.medxy.ai/vi/syndecan4-piezo1-thrombosis-2/Medxy AIvi2026-10-07T06:44:59-07:00Giải mã vai trò cơ chế của Syndecan-4 và Piezo1 trong huyết khối tĩnh mạch sâu: Gợi ý điều trị từ Quercetin https://news.medxy.ai/unraveling-the-mechanistic-role-of-syndecan-4-and-piezo1-in-deep-vein-thrombosis-therapeutic-insights-from-quercetin/Medxy AIen2026-10-07T06:44:35-07:00Unraveling the Mechanistic Role of Syndecan-4 and Piezo1 in Deep Vein Thrombosis: Therapeutic Insights from Quercetin https://news.medxy.ai/zh/adult-congenital-heart-disease/Medxy AIzh2026-10-07T06:43:41-07:00成人先天性心脏病：在不断演变的医疗格局中实现终身管理 https://news.medxy.ai/ja/81530-2/Medxy AIja2026-10-07T06:43:13-07:00成人先天性心疾患：絶えず変化する医療環境下での生涯にわたる管理の実現 https://news.medxy.ai/vi/adult-congenital-heart-disease-2/Medxy AIvi2026-10-07T06:42:31-07:00Bệnh tim bẩm sinh ở người trưởng thành: Hành trình chăm sóc suốt đời trong bối cảnh y tế không ngừng đổi thay https://news.medxy.ai/adult-congenital-heart-disease-navigating-lifelong-care-in-an-evolving-health-landscape/Medxy AIen2026-10-07T06:42:12-07:00Adult Congenital Heart Disease: Navigating Lifelong Care in an Evolving Health Landscape https://news.medxy.ai/ja/left-main-pci-imaging-2/Medxy AIja2026-10-07T06:41:30-07:00左主幹部PCIにおける血管内イメージング：2026年EAPCI–EBC臨床コンセンサスの要点 https://news.medxy.ai/vi/imaging-for-left-main-pci/Medxy AIvi2026-10-07T06:40:59-07:00Chẩn đoán hình ảnh trong lòng mạch cho PCI thân chung trái: các khuyến nghị then chốt từ đồng thuận lâm sàng EAPCI–EBC 2026 https://news.medxy.ai/zh/pci-imaging-consensus/Medxy AIzh2026-10-07T06:40:25-07:00左主干 PCI 的冠内影像应用：2026 年 EAPCI–EBC 临床共识核心要点 https://news.medxy.ai/left-main-pci-imaging/Medxy AIen2026-10-07T06:39:54-07:00Intracoronary imaging for left main PCI: key recommendations from the 2026 EAPCI–EBC clinical consensus https://news.medxy.ai/zh/type-2-diabetes-management-4/Medxy AIzh2026-10-07T06:31:50-07:002型糖尿病血糖管理再升级：数字疗法 Glucura 联合 CGM，6 个月疗效更优 https://news.medxy.ai/ja/type-2-diabetes-management-3/Medxy AIja2026-10-07T06:31:32-07:002型糖尿病の血糖管理をさらに高める：デジタル治療 glucura と CGM の併用で6か月成績が大きく改善 https://news.medxy.ai/vi/81507-2/Medxy AIvi2026-10-07T06:31:10-07:00Nâng cao hiệu quả kiểm soát đường huyết ở bệnh nhân đái tháo đường tuýp 2: Kết quả cải thiện đáng kể sau 6 tháng khi kết hợp liệu pháp kỹ thuật số Glucura và CGM https://news.medxy.ai/enhanced-glycaemic-control-in-type-2-diabetes-digital-therapeutic-glucura-combined-with-cgm-shows-superior-6-month-outcomes/Medxy AIen2026-10-07T06:30:44-07:00Enhanced Glycaemic Control in Type 2 Diabetes: Digital Therapeutic Glucura Combined with CGM Shows Superior 6-Month Outcomes https://news.medxy.ai/zh/81504-2/Medxy AIzh2026-10-07T06:29:55-07:00肝脏来源的ApoJ破坏脂质稳态并加重糖尿病性肾损伤 https://news.medxy.ai/ja/apoj-lipid-disorder/Medxy AIja2026-10-07T06:29:36-07:00肝由来ApoJが脂質恒常性を乱し糖尿病性腎障害を悪化させる https://news.medxy.ai/vi/81502-2/Medxy AIvi2026-10-07T06:29:14-07:00ApoJ có nguồn gốc từ gan làm rối loạn cân bằng nội môi lipid và làm trầm trọng thêm bệnh thận do đái tháo đường https://news.medxy.ai/liver-derived-apolipoprotein-j-drives-diabetic-kidney-injury-by-disrupting-lipid-homeostasis/Medxy AIen2026-10-07T06:28:50-07:00Liver-Derived Apolipoprotein J Drives Diabetic Kidney Injury by Disrupting Lipid Homeostasis https://news.medxy.ai/zh/81499-2/Medxy AIzh2026-10-07T06:28:07-07:00急性NAION视神经乳头水肿速度可预测视功能预后恶化 https://news.medxy.ai/ja/naion-optic-disc-swelling/Medxy AIja2026-10-07T06:27:43-07:00急性NAIONの視神経乳頭腫脹速度は視機能予後の悪化を予測する：エビデンスレビュー https://news.medxy.ai/vi/81497-2/Medxy AIvi2026-10-07T06:27:17-07:00Tốc độ phù gai thị trong bệnh NAION cấp tính dự báo sự xấu đi của tiên lượng chức năng thị giác: Đánh giá bằng chứng https://news.medxy.ai/early-optic-nerve-head-swelling-rate-predicts-visual-outcome-deterioration-in-nonarteritic-anterior-ischemic-optic-neuropathy-an-evidence-based-review/Medxy AIen2026-10-07T06:26:52-07:00Early Optic Nerve Head Swelling Rate Predicts Visual Outcome Deterioration in Nonarteritic Anterior Ischemic Optic Neuropathy: An Evidence-Based Review https://news.medxy.ai/zh/placenta-penetration-removal/Medxy AIzh2026-10-07T06:03:08-07:00基于病理解剖学的胎盘穿透性植入局灶切除：应对新生血管化难题的保宫策略 https://news.medxy.ai/ja/81583-2/Medxy AIja2026-10-07T06:02:49-07:00病理解剖学的知見に基づく胎盤穿通性癒着胎盤の局所切除：新生血管形成という難題に対処する子宮温存戦略 https://news.medxy.ai/vi/81582-2/Medxy AIvi2026-10-07T06:02:28-07:00Cắt bỏ khu trú nhau cài răng lược xuyên cơ dựa trên giải phẫu bệnh: Chiến lược bảo tồn tử cung nhằm giải quyết thách thức về sự tân tạo mạch máu https://news.medxy.ai/zh/hifu-twin-twin-transfusion/Medxy AIzh2026-10-07T06:01:27-07:00超声引导高强度聚焦超声：早发型双胎输血综合征胎盘血管闭塞的新选择 https://news.medxy.ai/ja/early-twin-transfusion-treatment/Medxy AIja2026-10-07T06:01:09-07:00早発性双胎間輸血症候群に対する超音波ガイド下高強度集束超音波――胎盤血管を安全に閉塞しうる新規治療の検討 https://news.medxy.ai/vi/hifu-placental-blood-flow/Medxy AIvi2026-10-07T06:00:48-07:00Khám phá HIFU có hướng dẫn bằng siêu âm trong bít tắc an toàn các mạch máu nhau thai ở hội chứng truyền máu song thai khởi phát sớm